|
|
|
Published online before print
August 22, 2002, 10.1101/gr.157802
Vol. 12, Issue 9, 1428-1433, September 2002
METHODS
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
A DNA mutation detection protocol able to identify and characterize a previously unknown change in a given sequence in a rapid, efficient, sensitive, and inexpensive manner is required to take advantage of the resources now available to researchers through the genome sequencing projects. We have developed a method based on base-specific cleavage of polymerase chain reaction (PCR) products and then separation of the fragments by matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS), which can meet these criteria. Differences are seen as the presence, absence, or mass change of peaks corresponding to fragments affected by the base difference. This technique is shown through the detection of a polymorphism in the 3' untranslated region of IL12p40 from a double-stranded PCR product, and the detection of a single nucleotide polymorphism between two mouse strains. The sensitivity of the technique can be increased with the use of postsource decay, which enables differentiation of two fragments of identical mass but different sequence. The level of specificity and the rapid sample analysis time lend this technique to the mass screening of individuals for sequence changes and, in combination with MS sequencing methods, could be used to facilitate rapid resequencing of DNA.
| |
INTRODUCTION |
|---|
|
|
|---|
DNA mutation detection protocols fall into two major categories:
those that are able to identify a previously unknown
change in a given sequence and those designed to find known mutations. The first category includes methods such as single-strand
conformational polymorphisms (Orita et al. 1989
) and denaturing
gradient gel electrophoresis (Lerman et al. 1986
)
which are rapid,
inexpensive, and useful as screening tools but lack sensitivity when
used on longer DNA fragments
and methods such as Sanger sequencing
(Orita et al. 1989
; Hattori et al. 1993
) and chemical cleavage (Cotton et al. 1988
), which can characterize the changed base but are expensive
and inefficient. Protocols identifying known mutations are now
frequently non-gel based and can be automated to give high throughput.
These include allele-specific polymerase chain reaction (PCR) and
specific oligonucleotide hybridization (Weber 1990
). A rapid, non-gel
based method for identifying unknown mutations is required. We describe
an approach in which matrix-assisted laser desorption ionization-time
of flight (MALDI-TOF) mass spectrometry (MS) and postsource decay (PSD)
fragmentation (Nordhoff et al. 1996
) are used to analyze the small
oligonucleotides resulting from a complete base-specific cleavage
reaction. Mutations appear as changes in mass peaks, and the sequence
change can be deduced from the mass of the new peak, the disappearance
of the wild-type peak, or sequence analysis of the PSD spectrum. The
theoretical sensitivity of the technique approaches that of Sanger
sequencing but eliminates the need for gel electrophoresis.
Most MS-based DNA sequencing protocols have focused on developing
methods for adapting Sanger sequencing reactions or on protocols for
base truncation of large DNA fragments. Although detection of DNA
fragments up to 622 bp in length have been reported, large fragments
cannot be accurately sized (Liu et al. 1995
). To achieve the high mass
accuracy required to describe point mutations, very small fragments are
required. A technique is therefore needed to reproducibly fragment
large DNA molecules. Although restriction endonuclease digestion has
been used (Bai et al. 1994
), the presence of restriction sites cannot
be guaranteed, and the usually large fragments generated preclude
accurate detection and characterization of base substitutions. We have
developed a mutation detection method that exploits the mass accuracy
of MALDI-TOF MS for short oligonucleotides but uses larger DNA
fragments as substrates. We have named this method TOFS for tiny
oligonucleotide fragment separation.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
The method we have developed uses a base-specific cleavage reaction
to generate the set of all small oligonucleotides bounded by the base
cleaved. These fragments are then separated based on mass by MALDI-TOF
MS, thus generating a fingerprint of the DNA fragments in which each
peak represents the mass of each small cleavage product. A different
mass peak is obtained for each oligonucleotide of a given length (up to
14 nucleotides) but different nucleotide composition (Pomerantz et al.
1993
). Any nucleotide substitution will result in either a peak shift
owing to the mass difference between the cleavage fragments or, if the
mutation changes the targeted base, a cleavage product containing a
different number of bases. DNA fragments >40 to 50 nucleotides in
length are not accurately detected in this system. Therefore, sequences
resulting in large fragments after base-specific cleavage, such as
those containing large numbers of tandem repeats, may be refractory to
analysis with this method.
Initial screening is performed by comparing the cleavage product masses of the wild-type allele to those of test samples. Differences corresponding to base changes will be observed. Accurate mass determination of each of these small fragments is possible, allowing unambiguous assignment of base composition for each oligonucleotide fragment. To detect mutations when both wild-type and mutated fragments are coincident with the masses of other oligonucleotides, quantitation of the number of molecules at that peak must be used. To differentiate between fragments of identical mass but different sequence, PSD is used as the resultant spectrum is based on the sequence of the oligonucleotide. This information allows deduction of the nature of the mutation and, after specific cleavage at different bases and integration of the data, the position of the mutation.
Although a number of methods are available to effect base specific
nucleotide cleavage (Maxam and Gilbert 1977
; Ambrose and Pless 1987
),
we have used uracil-N-glycosylase (UNG) to cleave the DNA at
uracil residues. Uracil is incorporated into the sequence by
replacement of dTTP with dUTP in the PCR (Warner and Duncan 1978
; Kwok
and Higuchi 1989
). The utility of this method is shown by the detection
of a sequence polymorphism in the IL-12p40 gene 3' untranslated region
(UTR; Huang et al. 2000
). This sequence change results in a
TaqI restriction fragment length polymorphism (RFLP) and
therefore can be followed by enzymatic digestion of PCR products. A PCR
assay was designed to incorporate the mutated region, and the product
was then subjected to treatment with UNG. The products were purified
and then analyzed by MALDI-TOF MS. The sequence of the PCR primers and
product, along with the mutation, are shown in Figure
1. The C-to-T change results in a
TaqI RFLP, which is seen in the homozygote and heterozygote
states in Figure 2. The
mass spectra generated by MALDI-TOF are also shown in Figure 2. The
expected and observed masses of the cleavage products from both alleles
are given in Table 1. The position of the
mutation and identity of the changed base can be deduced from this
data.
|
|
|
To decrease the complexity of the spectra produced by the cleavage of
double-stranded PCR products, a protocol for cleavage of only one
strand was also devised. Magnetic streptavidin beads were used to bind
PCR products containing a biotin moiety attached 5' to the forward
strand. The PCR product spans a known single nucleotide polymorphism
(SNP), and the predicted molecular weight of the digest fragment
containing the SNP can be seen in Table 2.
Incubation with NaOH results in the elution and removal of the
unbiotinylated reverse strand. The bound forward strand of the PCR
product can then be digested using UNG. Spectra showing both forms of
the polymorphism can be seen in Figure 3.
The removal of the reverse strand to produce a single-stranded PCR
product reduces the number of potential fragments generated by UNG
digestion that complicate spectra and analysis. A second pair of
reactions with biotin incorporated into the reverse strand will then
allow analysis of that strand to produce the complementary spectra
(data not shown). This will add to the sensitivity of this technique.
|
|
The utility of MALDI-TOF analysis coupled with PSD is shown in
Figure 4, in which the mass spectra of
two oligonucleotides of identical nucleotide composition (and
therefore identical MALDI-TOF profile) are presented. The resulting
PSD spectra are quite distinguishable and are based on the
characteristic fragmentation of each of the oligonucleotides. As the
sequence determination of small oligonucleotides is feasible using
molecular dissociation methods (Nordhoff et al. 1996
), the
extrapolation of this mutation detection protocol into an accurate
resequencing protocol seems possible.
|
The level of specificity possible using this technique and the rapid sample analysis time lend this technique to the mass screening of individuals for sequence changes. In combination with MS-based sequencing, it is likely that this technique could be used to resequence kilobase lengths of DNA. Before this happens, sample purification needs to be refined and automated, and the fragmentation patterns of short oligonucleotides need to be better understood.
| |
METHODS |
|---|
|
|
|---|
Genomic DNA from human volunteers of each possible genotype of the
IL-12p40 3'-UTR polymorphism (i.e., +/+, +/
, and
/
, in which + is
the presence of the Taq restriction site) were isolated using standard
methods. PCRs were performed in 20 µL reactions in 192-well plates in
a Corbett thermocycler with the following reaction mixture: 50 mM KCl;
10 mM Tris-HCl (pH 8.3); 2.5 mM MgCl2; 0.15 mM dATP, dCTP,
and dGTP (Promega); 5 mM dUTP (Boehringer Mannheim GmBH); 0.5 U
AmpliTaq Gold (Perkin Elmer); and 0.4 µM primers (Bresatec; sequence
shown in Fig. 1). After an initial 15-min incubation at 95°C, the
reactions were cycled for 15 sec at 95°C, for 35 sec at 58°C, and
for 35 sec at 72°C for 40 cycles. Seven reactions were pooled for the
homozygotes; nine reactions, for the heterozygote. One unit of AmpErase
UNG (Perkin Elmer) was added to each pool, and the reaction was
incubated for 1 h at 50°C, followed by 30 min at 105°C. The extent
of completion of the cleavage reaction was monitored by the absence of
the full-length band on an agarose gel. The cleavage products were
purified by reverse-phase high-performance liquid chromography on a
100 × 2.1-mm-internal-diameter C8 aquapore RP300 column (Applied
Biosystems). The flow rate was 0.5 mL/min, and absorbance was monitored
at 254 nm. The sample was loaded onto the column, washed with 0.1 M
triethylammoniumacetate (TEAA), and eluted using 0.1 M TEAA/60% acetonitrile. The fraction with absorbance at 254 nm was collected and
evaporated to dryness using a Savant Speedivac. The residue was
resuspended in 100 µL distilled deionized water, evaporated to
dryness, and then resuspended in 1 µL water; 0.5 µL of this was
mixed with 0.5 µL 3-hydroxypicolinic acid (saturated solution in 50%
acetonitrile) and 0.5 µL NH4+ ion-exchange beads (BioRad, 50W-X4;
mesh size, 100 to 200 µm) on the MALDI-TOF sample slide. A Voyager
BioSpectrometry workstation equipped with delayed extraction ionization
from PerSeptive Biosystems was used to characterize the reaction
products. One hundred twenty-eight laser pulses at power 1800 (arbitrary value) were averaged. Samples were calibrated externally
using oligonucleotides of known molecular weight.
Genotypes were confirmed by showing the presence or absence of the TaqI restriction site by digesting PCR products with TaqI restriction enzyme (GIBCO BRL) and analyzing the products by agarose electrophoresis. DNA bands were stained with ethidium bromide.
To reduce the number of fragments generated by UNG digestion of double-stranded (DS) PCR products, Streptavidin-coated magnetic beads were used to remove the reverse strand. Two hundred-bp PCR products were amplified using genomic mouse DNA from two strains, SJL and C57BL/6, with the PCR product spanning a SNP located on chromosome 9, which is "A" in SJL and "G" in C57BL/6.
One hundred microliters of PCRs were performed in 96-well plates using a M.J. Research PTC 200 thermal cycler with the reaction mixture of 50 mM KCl; 20 mM Tris; 2.5 mM MgCl2; 0.15 mM dATP, dGTP, dCTP, dUTP (Pharmacia); and 1.0 U Taq polymerase (Perkin Elmer) plus 5 µM of biotinylated forward primer (biotin 5'-GCACCATCAGAGCTGTCAAACCCAT-3') and 5 µM of reverse primer (5'-AGTATCCACCCCCAGAGCTTGTTAA-3'; Sigma). After an initial incubation for 2 min at 94°C, the reactions were cycled for 20 sec at 94°C, for 30 sec at 60°C, and for 1.30 min at 72°C for 30 cycles; 10 × 100 µL PCRs for each strain were pooled, and ethanol precipitated. The PCR products were further purified using QIAquick gel extraction kit (Qiagen), as instructed, to remove excess biotinylated primers.
The PCR products were resuspended in 1 mL bead binding buffer (1 M NaCl, 5 mM Tris, and 0.5 mM EDTA; Sigma) and coupled to 20 µL of streptavidin-coated magnetic beads (Scipac 10 mg/mL) for 1 h at room temperature. The beads were washed with 0.2 M NaOH (Sigma) for 5 min to remove the unbound reverse strand, followed by repeated washing (×5) with water and resuspension in 100 µL of UNG buffer (MBI). The beads with the remaining bound forward strand were digested using 5 U UNG overnight at 37°C.
After digestion, 5 µL of NH4OH (Aldrich) was added, and the
sample was heated for 5 min at 95°C to induce strand fragmentation. The sample beads were precipitated using a magnet (Dynal), and the
supernatant was collected in a new tube. The beads were washed once
with 50 µL of water and pooled with the digest supernatant. The
digest mix was dried down in a rotary evaporator (Christ
RCV) to
remove excess water and NH4OH. The dried sample was suspended in ~10 µL of water and further purified using an A.B. Nucleic Acid
Purification kit for SequazymeTM (courtesy of Applied Biosystems).
The sample was dried down to 1 µL and then mixed with 1 µL of MALDI-TOF matrix 2,4,6-trihydroxyacetophenone monohydrate (THAP) 10 mg/mL dissolved in 50% acetonitrile in water; 1 µL of sample plus matrix was spotted on a sample plate and analyzed using a Perseptive Biosystems Voyager-DE Pro MALDI-TOF MS. Spectra were obtained in linear mode using negative ions with delayed extraction of 650 ns, with up to 256 averaged 377-nm laser pulses. Samples were calibrated externally using oligonucleotides of known molecular weight.
PSD spectra were obtained using a Kratos Kompact MALDI4 TOF MS equipped with a 377-nm laser and a curved field reflector in positive ion mode. Matrix and sample preparation were as outlined above. After obtaining a mass spectrum in linear mode, PSD fragmentation was performed by setting an ion gate width of ~100 Da around the ion of interest (m/z 1727.2) in reflectron mode. Two hundred profiles were acquired at a rate of five laser shots per profile. Spectra were calibrated externally using a 1 pmole/µL solution of human angiotensin I (m/z 1297.5) and a matrix-derived ion (m/z 173.2) with the ion gate switched off.
| |
ACKNOWLEDGMENTS |
|---|
We acknowledge the contribution of the Wellcome Trust (SF), Bruce Kemp, Ken Mitchelhill, Grant Morahan, Dexing Huang, Sue Forrest, Eric Reynolds, and Vikki Marshall.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
FOOTNOTES |
|---|
4 Corresponding author.
E-MAIL foote{at}wehi.edu.au; FAX +613 9347-0852.
Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.157802. Article published online before print in August 2002.
| |
REFERENCES |
|---|
|
|
|---|
Received February 6, 2002; accepted in revised form June 12, 2002.
This article has been cited by other articles:
![]() |
P. Stanssens, M. Zabeau, G. Meersseman, G. Remes, Y. Gansemans, N. Storm, R. Hartmer, C. Honisch, C. P. Rodi, S. Bocker, et al. High-Throughput MALDI-TOF Discovery of Genomic Sequence Polymorphisms Genome Res., January 1, 2004; 14(1): 126 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hartmer, N. Storm, S. Boecker, C. P. Rodi, F. Hillenkamp, C. Jurinke, and D. van den Boom RNase T1 mediated base-specific cleavage and MALDI-TOF MS for high-throughput comparative sequence analysis Nucleic Acids Res., May 1, 2003; 31(9): e47 - e47. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||